Beta Drugs Ltd Q4 FY2025-2026 Results: Summary
Revenue | ₹96.86Cr |
Net Profits | ₹9.05Cr |
Net Profit Margins | 9.34% |
Beta Drugs Ltd’s revenue fell -0.89% since last year same period to ₹96.86Cr in the Q4 2025-2026. On a quarterly growth basis, Beta Drugs Ltd has generated 8.13% jump in its revenue since last 3-months.
Beta Drugs Ltd’s net profit jumped 0.22% since last year same period to ₹9.05Cr in the Q4 2025-2026. On a quarterly growth basis, Beta Drugs Ltd has generated 6.22% jump in its net profits since last 3-months.
Beta Drugs Ltd’s net profit margin jumped 1.12% since last year same period to 9.34% in the Q4 2025-2026. On a quarterly growth basis, Beta Drugs Ltd has generated -1.76% fall in its net profit margins since last 3-months.
FAQs
What was the revenue for Beta Drugs Ltd in Q4 results 2025?
The revenue for Beta Drugs Ltd in the Q4 results 2025 was ₹96.86Cr.
What was the net profit for Beta Drugs Ltd in Q4 results 2025?
The net profit for Beta Drugs Ltd in the Q4 results 2025 was ₹9.05Cr.
What was the net profit margin for Beta Drugs Ltd in Q4 results 2025?
The net profit margin for Beta Drugs Ltd in the Q4 results 2025 was 9.34%.
What was the revenue for Beta Drugs Ltd in Q4 results 2024?
The revenue for Beta Drugs Ltd in the Q4 results 2024 was ₹97.73Cr.
What was the net profit for Beta Drugs Ltd in Q4 results 2024?
The net profit for Beta Drugs Ltd in the Q4 results 2024 was ₹9.03Cr.
What was the net profit margin for Beta Drugs Ltd in Q4 results 2024?
The net profit margin for Beta Drugs Ltd in the Q4 results 2024 was 9.24%.
